TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,765,088 | -94.9% | 928,838 | -84.7% | 0.00% | -92.3% |
| Q2 2023 | $151,049,491 | -13.7% | 6,080,897 | -47.8% | 0.01% | +62.5% |
| Q1 2023 | $175,066,696 | +105.9% | 11,640,072 | +61.9% | 0.01% | 0.0% |
| Q4 2022 | $85,044,237 | +86.1% | 7,188,862 | -6.9% | 0.01% | +60.0% |
| Q3 2022 | $45,704,000 | +33.5% | 7,720,224 | -4.1% | 0.01% | +66.7% |
| Q2 2022 | $34,232,000 | -82.3% | 8,054,461 | -60.4% | 0.00% | -80.0% |
| Q1 2022 | $193,328,000 | -50.9% | 20,328,841 | -1.9% | 0.02% | -48.3% |
| Q4 2021 | $393,707,000 | -38.6% | 20,721,431 | +7.5% | 0.03% | -43.1% |
| Q3 2021 | $641,239,000 | -11.5% | 19,268,002 | +3.2% | 0.05% | -10.5% |
| Q2 2021 | $724,501,000 | -16.4% | 18,677,515 | +3.9% | 0.06% | -23.0% |
| Q1 2021 | $866,185,000 | +12.3% | 17,970,651 | +21.2% | 0.07% | +7.2% |
| Q4 2020 | $771,308,000 | +162.9% | 14,827,136 | +35.3% | 0.07% | +130.0% |
| Q3 2020 | $293,330,000 | +19.0% | 10,961,505 | -13.4% | 0.03% | +11.1% |
| Q2 2020 | $246,487,000 | +163.0% | 12,653,286 | +32.9% | 0.03% | +107.7% |
| Q1 2020 | $93,709,000 | +381.5% | 9,523,241 | +443.1% | 0.01% | +550.0% |
| Q4 2019 | $19,463,000 | +88.8% | 1,753,444 | -4.5% | 0.00% | +100.0% |
| Q3 2019 | $10,309,000 | -41.2% | 1,835,920 | -9.4% | 0.00% | -50.0% |
| Q2 2019 | $17,534,000 | -9.2% | 2,027,037 | -15.6% | 0.00% | 0.0% |
| Q1 2019 | $19,312,000 | +73.0% | 2,402,037 | -11.8% | 0.00% | 0.0% |
| Q4 2018 | $11,166,000 | -32.3% | 2,723,437 | -7.5% | 0.00% | 0.0% |
| Q3 2018 | $16,491,000 | -64.8% | 2,944,733 | -17.4% | 0.00% | -60.0% |
| Q2 2018 | $46,899,000 | -30.2% | 3,566,433 | -24.6% | 0.01% | -37.5% |
| Q1 2018 | $67,155,000 | +65.4% | 4,729,233 | -4.5% | 0.01% | +60.0% |
| Q4 2017 | $40,600,000 | -46.9% | 4,951,213 | -23.3% | 0.01% | -44.4% |
| Q3 2017 | $76,453,000 | +17.9% | 6,451,713 | 0.0% | 0.01% | +12.5% |
| Q2 2017 | $64,840,000 | -13.7% | 6,451,713 | 0.0% | 0.01% | -20.0% |
| Q1 2017 | $75,162,000 | +326.4% | 6,451,713 | +70.2% | 0.01% | +400.0% |
| Q4 2016 | $17,627,000 | -53.1% | 3,790,764 | -22.0% | 0.00% | -60.0% |
| Q3 2016 | $37,615,000 | +27.7% | 4,859,764 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $29,450,000 | -42.6% | 4,859,764 | -19.3% | 0.00% | -42.9% |
| Q1 2016 | $51,337,000 | -31.3% | 6,025,425 | -3.8% | 0.01% | -30.0% |
| Q4 2015 | $74,709,000 | +24.3% | 6,262,307 | +5.0% | 0.01% | +11.1% |
| Q3 2015 | $60,110,000 | -6.5% | 5,963,301 | +53.9% | 0.01% | +12.5% |
| Q2 2015 | $64,284,000 | +35.7% | 3,874,842 | +26.6% | 0.01% | +33.3% |
| Q1 2015 | $47,385,000 | +55.2% | 3,061,070 | +58.8% | 0.01% | +50.0% |
| Q4 2014 | $30,536,000 | +13655.0% | 1,927,803 | +4321.6% | 0.00% | – |
| Q3 2013 | $222,000 | – | 43,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |